semaglutide cancer risk GLP-1s appear to cut risk. Researchers are asking why and how : NPR GLP-1 drugs and cancer: the

How the shipment arrives is observable evidence about the operation behind it, and it is one of the few quality signals a patient can assess directly

Clinical trials demonstrate that semaglutide patients lost an average of 14-22% of body weight over 68 weeks in the STEP trials

CLEAR + BRILLIANT LASER Rejuvenate your skin with the Clear + Brilliant Laser treatment

Sustained nitric oxide enhancement might trigger adaptive responses that alter the cardiovascular system over time

Targeting neuroinflammation: the therapeutic potential of -3 PUFAs in substance abuse

Although the mechanisms by which HRT promotes neuroprotection are mostly unknown, it has been proposed that signaling pathways mediated by both classical estrogen receptors and GPER-1 are involved in the anti-oxidant and anti-inflammatory effects of estrogens in nervous tissue (Unfer et al., 2015